Dihydro-alpha-ergocryptine mesylate is a salt form of an ergoline derivative used as an active pharmaceutical ingredient in the manufacturing of certain medications. It functions as a dopamine agonist and is structurally related to bromocriptine.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 14271-05-7
Dihydroergocristine mesylate
pharmaceutical raw material
Acidihydroergocristine
pharmaceutical raw material
Dihydroergotamine mesylate
pharmaceutical raw material
Cinacalcet Related Compound C
pharmaceutical raw material
Xipamide
pharmaceutical raw material
1-(4-((4-((1,2,4)triazolo(1,5-a)pyrid-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-3-(1-hydroxy-2-methylpropan-2-yl)thiourea
pharmaceutical raw material
Vinblastine sulfate
pharmaceutical raw material
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
TZGKQIBPZOZAKF-PJLVGBPESA-N
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4C[C@H]5[C@@H](CC6=CNC7=CC=CC5=C67)N(C4)C)O.CS(=O)(=O)O